Related references
Note: Only part of the references are listed.Defining Immunogenic and Radioimmunogenic Tumors
Terry R. Medler et al.
FRONTIERS IN ONCOLOGY (2021)
The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors
Tiffany C. Blair et al.
FRONTIERS IN ONCOLOGY (2021)
Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors
Emma J. de Ruiter et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy
Tiffany C. Blair et al.
JOURNAL OF IMMUNOLOGY (2020)
Exploring Alzheimer's Disease Molecular Variability via Calculation of Personalized Transcriptional Signatures
Hila Dagan et al.
BIOMOLECULES (2020)
Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review
Volker Budach et al.
LANCET ONCOLOGY (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E. W. Cohen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy
Efrat Flashner-Abramson et al.
THERANOSTICS (2019)
Prognostic Significance of Stromal Versus Intratumoral Infiltrating Lymphocytes in Different Subtypes of Breast Cancer Treated With Cytotoxic Neoadjuvant Chemotherapy
Thaer Khoury et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome
Sven Schneider et al.
HISTOPATHOLOGY (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Personalized disease signatures through information-theoretic compaction of big cancer data
Swetha Vasudevan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen et al.
NATURE COMMUNICATIONS (2018)
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Marka R. Crittenden et al.
SCIENTIFIC REPORTS (2018)
Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma
Jason R. Baird et al.
CANCER RESEARCH (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Pan-cancer deconvolution of tumour composition using DNA methylation
Ankur Chakravarthy et al.
NATURE COMMUNICATIONS (2018)
Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer
Ephraim S. Tang et al.
JAMA SURGERY (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
Tim Mueller et al.
ONCOTARGET (2017)
The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
Emma J. de Ruiter et al.
ONCOIMMUNOLOGY (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40
David J. Messenheimer et al.
CLINICAL CANCER RESEARCH (2017)
Multiparametric immune profiling in HPV-oral squamous cell cancer
Zipei Feng et al.
JCI INSIGHT (2017)
CD8+tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)
Panagiotis Balermpas et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
Sara Gandini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
Nghia Nguyen et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Multispectral Imaging of T and B Cells in Murine Spleen and Tumor
Zipei Feng et al.
JOURNAL OF IMMUNOLOGY (2016)
Blockade of PD-1 Signaling Enhances Th2 Cell Responses and Aggravates Liver Immunopathology in Mice with Schistosomiasis japonica
Sha Zhou et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer
Harrison Cash et al.
ONCOTARGET (2015)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer
Jian L. Campian et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
Stefani Spranger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Mark J. Selby et al.
CANCER IMMUNOLOGY RESEARCH (2013)
ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness
Nancy P. Judd et al.
CANCER RESEARCH (2012)
PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer
John Dulos et al.
JOURNAL OF IMMUNOTHERAPY (2012)
On a fundamental structure of gene networks in living cells
Nataly Kravchenko-Balasha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
Michael A. Curran et al.
PLOS ONE (2011)
Activation of OX40 Augments Th17 Cytokine Expression and Antigen-Specific Uveitis
Zili Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Information-theoretic analysis of phenotype changes in early stages of carcinogenesis
F. Remacle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
Michael A. Curran et al.
CANCER RESEARCH (2009)
CELL CYCLE AND VIRAL AND IMMUNOLOGIC PROFILES OF HEAD AND NECK SQUAMOUS CELL CARCINOMA AS PREDICTABLE VARIABLES OF TUMOR PROGRESSION
Massimo Ritta et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
Carl E. Ruby et al.
JOURNAL OF IMMUNOLOGY (2009)
pcaMethods - a bioconductor package providing PCA methods for incomplete data
Wolfram Stacklies et al.
BIOINFORMATICS (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
Sergio A. Quezada et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation
S Salek-Ardakani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Share Paper
